Skip to main content

Advertisement

SpringerLink
Log in

Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene

  • Letters to the editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Surgery, Koshigaya Hospital, Dokkyo University, School of Medicine, 2-1-50 Minamikoshigaya, Koshigaya, 343-8555, Japan

    Masahiko Yamaguchi & Tadashi Matsumoto

  2. Department of Clinical Pathology, Showa University Fujigaoka Hospital, Yokohama, Japan

    Genshu Tate

  3. Department of Hematology, Showa University Fujigaoka Hospital, Yokohama, Japan

    Takakazu Higuchi

Authors
  1. Masahiko Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadashi Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Genshu Tate
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takakazu Higuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaguchi, M., Matsumoto, T., Tate, G. et al. Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene. J Gastroenterol 39, 904–905 (2004). https://doi.org/10.1007/s00535-003-1409-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-003-1409-z

Keywords

Search

Navigation